RE: Dr Huw Jones, CEO of TheraCryf plc, on Positive Ox-1 Toxicology Data, Commercial Partner Interest and the Path to Human Trials16 May 2026 10:01
An offer has already been made above the current market cap. Only a matter of time before higher offers come in, which could be multiples of the share price at present.